ClinicalTrials.Veeva
Menu

Find clinical trials for COVID-19 in Kansas City, KS

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Coronavirus Infections
Infections
Post-Acute COVID-19 Syndrome
Human Influenza
Pneumonia
Respiratory Tract Infections
Virus Diseases

COVID-19 trials near Kansas City, KS, USA:

Study of VYD2311 for the Prevention of COVID-19 (DECLARATION)

The main purpose of this study is to test an investigational drug known as VYD2311, which is being developed to lower the risk of getting COVID...

Active, not recruiting
COVID-19
Drug: VYD2311-SD
Drug: VYD2311-MD

Phase 3

Invivyd

Independence, Missouri, United States and 19 other locations

multi-center clinical trial (RCT) of SPI-1005 in adult subjects with positive PCR test for novel SARS-CoV-2 (nCoV2) and moderate symptoms of COVID...

Invitation-only
Covid19
Corona Virus Infection
Drug: Ebselen
Drug: Placebo

Phase 2

Sound Pharmaceuticals

Kansas City, Kansas, United States and 6 other locations

multi-center clinical trial (RCT) of SPI-1005 in adult subjects with positive PCR test for novel SARS-CoV-2 (nCoV2) and severe symptoms of COVID...

Invitation-only
Covid19
Corona Virus Infection
Drug: Ebselen
Drug: Placebo

Phase 2

Sound Pharmaceuticals

Kansas City, Kansas, United States and 6 other locations

vaccine for the prevention of symptomatic Coronavirus Disease 2019 (COVID-19).In order to represent a more recently circulating SAR...

Active, not recruiting
COVID-19
SARS-CoV2
Biological: VXA-CoV2-3.1
Biological: VXA-CoV2-3.3

Phase 2

Vaxart

Kansas City, Missouri, United States and 144 other locations

Status recently updated

This is a Phase 4, post-market US study, evaluating the efficacy and safety of a single dose of the NVX-CoV2705 Omicron JN.1 COVID-19...

Not yet enrolling
Active, not recruiting
COVID-19
Sars-CoV-2 Infection
Biological: NVX-CoV2705
Biological: Placebo

Phase 4

Novavax
Novavax

Kansas City, Missouri, United States and 98 other locations

seek to enroll immunocompromised patients with Lower Tract parainfluenza infection.It also contains a sub-study to enroll patients with severe COVID...

Enrolling
COVID-19
Parainfluenza
Drug: DAS181 COVID-19
Drug: DAS181

Phase 3

Ansun Biopharma

Fairway, Kansas, United States and 66 other locations

This study is a Phase 3 trial designed to check the safety and immune response to a new Omicron JN.1 COVID-19 vaccine. Study resear-...

Active, not recruiting
COVID-19
SARS-CoV-2 Infection
Biological: NVX-CoV2705

Phase 3

Sanofi
Sanofi

Lenexa, Kansas, United States and 9 other locations

Status recently updated

The purpose of this study is to learn about the safety and effects of the vaccine (called COMIRNATY) for the potential prevention of COVID-19...

Enrolling
Active, not recruiting
Myocarditis
Diagnostic Test: Cardiac Imaging

Phase 4

Pfizer
Pfizer

Kansas City, Missouri, United States and 17 other locations

the efficacy and safety of mRNA-1283 and mRNA-1273 (variant formulations) in adults 50 to 64 years of age without high risk factors for severe COVID...

Active, not recruiting
SARS-CoV-2
Biological: mRNA-1283
Biological: mRNA-1273

Phase 4

Moderna
Moderna

Kansas City, Missouri, United States and 149 other locations

against infection with SARS-CoV-2, the novel coronavirus causing COVID-19 disease. The investigational vaccine, MV-014-212, is a li...

Enrolling
Covid19
Biological: Investigational vaccine against SARS-CoV-2 [MV-014-212] Dosage 3, Single Dose, Intranasal Drops
Biological: Investigational vaccine against SARS-CoV-2 [MV-014-212] Dosage 2, Single Dose, Intranasal Drops

Phase 1

Meissa Vaccines

Lenexa, Kentucky, United States of America and 1 other location

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems